Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain
NCT07921771, Not applicable, Not yet recruiting, Istinye University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain | ClinicalTrials.gov |
| NCT number | NCT07921771 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 48 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Istinye University | ClinicalTrials.gov |
| Conditions | Nonspecific Low Back Pain | ClinicalTrials.gov |
| Interventions | Core Stabilization Exercises, Whole-Body Vibration, Cervical Stabilization Exercises | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Trunk motor control (supine), Pressure Biofeedback Unit | Baseline and immediately after the single intervention session | Deep abdominal muscle activation and lumbopelvic stability assessed with a pressure biofeedback unit in crook lying during the abdominal drawing-in maneuver, starting at 40 mmHg. The score is the absolute deviation from 40 mmHg (best of three trials); smaller values indicate better motor control. | ClinicalTrials.gov |
| Primary | Trunk motor control (prone; transversus abdominis activation), Pressure Biofeedback Unit | Baseline and immediately after the single intervention session | Activation of the transversus abdominis assessed in prone lying with the pressure biofeedback unit placed under the abdomen and inflated to 70 mmHg. Participants draw the abdominal wall in without moving the spine or pelvis. The score is the pressure reduction from 70 mmHg held steadily (best of three trials); larger reductions indicate better activation. | ClinicalTrials.gov |
| Secondary | Pain intensity, Numeric Pain Rating Scale (NPRS) | Baseline and immediately after the single intervention session | Self-reported low back pain intensity rated from 0 (no pain) to 10 (worst imaginable pain). Lower scores indicate less pain. | ClinicalTrials.gov |
| Secondary | Pressure pain threshold, lumbar multifidus | Baseline and immediately after the single intervention session | Pressure pain threshold in kg/cm² measured with a pressure algometer 2 cm lateral to the L4 spinous process. The mean of three measurements is used. Higher values indicate lower pain sensitivity. | ClinicalTrials.gov |
| Secondary | Pressure pain threshold, erector spinae | Baseline and immediately after the single intervention session | Pressure pain threshold in kg/cm² measured with a pressure algometer 3 cm lateral to the L3 spinous process. The mean of three measurements is used. Higher values indicate lower pain sensitivity. | ClinicalTrials.gov |
| Secondary | Pressure pain threshold, thoracolumbar fascia | Baseline and immediately after the single intervention session | Pressure pain threshold in kg/cm² measured with a pressure algometer 5 cm lateral to the L3 level. The mean of three measurements is used. Higher values indicate lower pain sensitivity. | ClinicalTrials.gov |
| Secondary | Y-Balance Test composite score, right leg | Baseline and immediately after the single intervention session | Maximum reach in the anterior, posteromedial and posterolateral directions while standing on the right leg, normalized to right lower limb length and expressed as a composite score (%). Higher scores indicate better dynamic balance. | ClinicalTrials.gov |
| Secondary | Y-Balance Test composite score, left leg | Baseline and immediately after the single intervention session | Maximum reach in the anterior, posteromedial and posterolateral directions while standing on the left leg, normalized to left lower limb length and expressed as a composite score (%). Higher scores indicate better dynamic balance. | ClinicalTrials.gov |
| Secondary | Trunk flexor endurance test | Baseline and immediately after the single intervention session | Isometric holding time in seconds in the trunk flexor endurance test (McGill). Longer holding time indicates greater trunk flexor endurance. | ClinicalTrials.gov |
| Secondary | Prone plank test | Baseline and immediately after the single intervention session | Isometric holding time in seconds in the prone plank position. Longer holding time indicates greater trunk muscle endurance. | ClinicalTrials.gov |
| Secondary | Right side bridge test | Baseline and immediately after the single intervention session | Isometric holding time in seconds in the right side bridge test (McGill). Longer holding time indicates greater lateral trunk endurance. | ClinicalTrials.gov |
| Secondary | Left side bridge test | Baseline and immediately after the single intervention session | Isometric holding time in seconds in the left side bridge test (McGill). Longer holding time indicates greater lateral trunk endurance. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)